My Size Inc.: MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale

MySize, Inc. (NASDAQ: MYSZ) reported Q2 2026 revenue of $3.07 million, up 53% year over year, and $5.46 million for the first half, up 57%. Percentil revenue rose to $413,000. Gross margin fell to about 31.7% as commerce mix increased. Net loss was $1.75 million. Cash used in operations was $1.97 million for six months.

Original reporting
Published Aug 14, 2026, 12:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MYSZ
Neutral
medium confidence
Mentioned
$MYSZ
Relevance
8/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$MYSZNeutralMed
01

Why it matters

Q2 results show strong growth but significant gross margin compression and higher operating and net losses, while cash burn improved in the first half. Management is explicitly shifting focus to contribution margin, operating leverage, and cash efficiency.

02

Market read

Traders get a fresh earnings datapoint with detailed segment mix, gross margin drivers, and cash flow changes, informing near-term valuation and risk around monetization.

03

What to watch

Cash usage improved and SaaS gross margin remained high (~86%), so the key swing factor is whether management can shift revenue mix and operating leverage in H2 2026.

Relevance 8/10Novelty 8/10Timing: reported Q2 and six-month results for period ended June 30, 2026 (published Aug. 14, 2026)

Background

MySize is scaling an integrated fashion technology platform spanning AI sizing, e-commerce, recommerce, and brand distribution, including Ten Peacks and Percentil.

Company-level read

Ticker impact

$MYSZNeutralMedium confidence
Context

MySize reported Q2 2026 revenue up 53% YoY to $3.07M, with gross margin falling to ~31.7% from ~56% as mix shifted toward commerce.

Expected impact

Likely choppy reaction, with traders weighing revenue momentum against weaker gross margin and larger losses.

Evidence & confidence

The article provides concrete financial datapoints (revenue, gross margin, operating loss, net cash used) and management’s stated pivot toward contribution margin and cash efficiency, which can support a rebound narrative but also highlights current economics pressure.

Market effects

Highlights margin sensitivity for fashion-tech platforms when commerce mix rises versus SaaS/recommerce.

No specific regional market catalyst beyond the company’s Israel-based operations.

Limited; primarily company-specific financial performance and integration progress.

Counterpoint

Revenue growth may be masking structural margin issues, since gross margin dropped sharply as commerce revenue mix increased.

Key entities

  • MySize, Inc.

    NASDAQ-listed fashion technology company reporting Q2 and six-month financial results and integration progress across its platform.

  • Ronen Luzon

    CEO quoted on scaling revenue and shifting priorities toward unit economics and cash efficiency.

  • Percentil

    Resale/recommerce platform within MySize, with quarterly revenue reported at $413,000.

  • Ten Peacks

    International apparel and footwear brand distribution business included in the platform, cited as contributing to growth and expense increases.

Related articles

$MYSZMed

My Size, Inc. (MYSZ): Results of Operations and Financial Condition

My Size, Inc. (MYSZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MySize Reports 53% Year-Over-Year Revenue Growth in Second Quarter 2026 as Integrated Fashion Platform Continues to Scale Quarterly revenue reaches $3.1 million; first-half revenue increases 57% to $5.5 million Company enters next phase focused on contribution margin

$TCOMMed

Citi is bullish on these 2 Chinese travel stocks heading into the autumn holidays

Citi reiterated Buy ratings on Tongcheng (THG) and Trip.com (TCOM), citing attractive valuations and upcoming holidays as potential catalysts. Tongcheng reported Q2 2026 revenue of RMB 5.0 billion and net profit of RMB 851 million. Trip.com faces near-term headwinds but is expected to outperform in 2027. Analysts adjusted TCOM's price target to $60, maintaining Buy ratings.

$EMAMed

Emera (EMA) Closes the Book on New Mexico, But Earnings Still Flinch

Emera (EMA) completed the sale of New Mexico Gas Company, marking the end of its asset divestment plan. Q2 2026 earnings showed adjusted EPS at $0.69, down from $0.79 in Q2 2025, due to higher interest expenses and currency losses. The company invested $1.7B in H1 2026 and expects $4B in capital expenditures for the year. Florida operations drove growth, with adjusted profit up to $441M in H1 2026. Management reaffirmed its 5-7% annual adjusted EPS growth target through 2030.

$HBANMed

Huntington Cut Its Outlook Right as the Fed Hiked. First Crack in Regional-Bank Margins?

Huntington Bancshares (HBAN) dropped 5.55% after lowering its 2027 EPS guidance to $1.75-$1.83 and 2026 net interest income growth to ~35%, citing rising deposit costs and loan pricing tightening. The Fed's rate hike exacerbated concerns about regional-bank margins, with peers like Fifth Third also seeing declines. Despite the selloff, Huntington's loan and deposit growth, along with fee income, provide some cushion. Analysts maintain an Overweight rating, with a price target of $21.